Voya Investment Management LLC Hutchmed (China) LTD Transaction History

Voya Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$15.52 - $35.65 $139,571 - $320,600	-8,993 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$35.66 - $42.94 $7,203 - $8,673	-202 Reduced 2.2%	8,993 $329,000
Q2 2021 Aug 16, 2021	BUY	$23.7 - $39.27 $41,119 - $68,133	1,735 Added 23.26%	9,195 $361,000
Q4 2020 Feb 16, 2021	BUY	$27.51 - $34.36 $205,224 - $256,325	7,460 New	7,460 $239,000
Q2 2019 Aug 14, 2019	SELL	$22.0 - $31.78 $145,530 - $210,224	-6,615 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$21.27 - $30.58 $140,701 - $202,286	6,615 New	6,615 $202,000

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.9B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.